Group A Streptococcus emm Gene Types in Pharyngeal Isolates, Ontario, Canada, 2002–2010
Patrick R. Shea, Amy L. Ewbank, Javier H. Gonzalez-Lugo, Alexandro J. Martagon-Rosado, Juan C. Martinez-Gutierrez, Hina A. Rehman, Monica Serrano-Gonzalez, Nahuel Fittipaldi, Stephen B. Beres, Anthony R. Flores, Donald E. Low, Barbara M. Willey, and James M. Musser
Author affiliations: The Methodist Hospital Research Institute, Houston, Texas, USA (P.R. Shea, A.L. Ewbank, J.H. Gonzalez-Lugo, A.J. Martagon-Rosado, J.C. Martinez-Gutierrez, H.A. Rehman, M. Serrano-Gonzalez, N. Fittipaldi, S.B. Beres, A.R. Flores, J.M. Musser); Texas Children’s Hospital, Houston (A.R. Flores); Baylor College of Medicine, Houston (A.R. Flores); Mount Sinai Hospital/University Health Network, Toronto, Ontario, Canada (D.E. Low, B.M. Willey); Ontario Agency for Health Protection and Promotion, Toronto (D.E. Low); University of Toronto, Toronto (D.E. Low)
Main Article
Figure 4
Figure 4. Frequency of emm89 strains among patients with group A Streptococcus pharyngitis and invasive disease, Ontario, Canada, 2002–2010, excluding 2004–2005. Black line indicates yearly frequency of emm89 among invasive disease isolates; red line indicates frequency of emm89 among pharyngeal isolates.
Main Article
Page created: October 24, 2011
Page updated: October 24, 2011
Page reviewed: October 24, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.